We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
15 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Swedish Orphan Biovitrum Pty Ltd - Mechanically-operated infusion pump set.
-
Jun-2025Prescription medicine evaluationActive ingredient: pegcetacoplan.
-
Designation or determinationPriority review
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Swedish Orphan Biovitrum Pty Ltd - Mechanically-operated infusion pump.
-
Designation or determinationOrphan drug
-
Mar-2025Prescription medicine evaluationActive ingredient: loncastuximab tesirine.
-
Prescription medicine registrationActive ingredients: pegcetacoplan.
-
Designation or determinationOrphan drug
-
Designation or determinationProvisional determination
-
Australian public assessment report (AusPar)Doptelet (avatrombopag) has been approved for the treatment of thrombocytopenia in adult patients with chronic liver disease and chronic immune thrombocytopenia.